Bioventus Inc.
BVS
NASDAQ·Healthcare·Medical - Devices·Mkt cap $953.2M
$14.07
▼ -2.02%
P/E
17.76
Mkt Cap
$953.2M
52-Wk Range
$6.26–$15.89
52-Week Range
$6.26 - $15.89
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 95.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Comprehensive product portfolio spanning the entire orthopedic continuum from pain management to surgical and restorative solutions
- Proprietary ultrasonic and regenerative technology platforms that enhance natural healing processes
- Established relationships with orthopedic specialists across multiple surgical disciplines and care settings
- Focus on minimally invasive alternatives addressing the market shift away from traditional surgical approaches
Bear Case
1 risk
- Low volatility (beta 0.7).
Growth
Stable outlook
Aging global population driving increased orthopedic procedures and chronic pain management demand
Value
Fairly valued vs Medical Devices peers
Momentum
Hot
+57.2% over 3m
Quality
Excellent
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying BVS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 5, 2026
Reported EPS of $0.22 vs $0.22 consensus (+1.7% surprise). Revenue of $153.2M vs $155.4M expected (-1.4%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+1.7%
Revenue trend · last 8Q
—
+13%
-4%
-2%
-0%
+3%
+7%
+4%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$139.0M
$153.6M
$123.9M
$147.7M
$138.7M
$157.9M
$132.1M
$153.2M
Margins · last 8Q
Gross
69.0%
Operating
12.5%
Profit
21.8%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Craig-Hallum · Aug 6, 2026
vs Industry
How BVS stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related